Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
We have now added a new section called the "Assay History List" to the "At A Gla...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...